ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

DCT Issues New Program Announcement On Clinical Research

December 5, 1980